Evogene Ltd (EVGN) Q3 2024 Earnings Call Highlights: Navigating Challenges and Seizing Opportunities [Yahoo! Finance]
Evogene Ltd. - Ordinary Shares (EVGN)
Last evogene ltd. - ordinary shares earnings: 2/28 07:00 am
Check Earnings Report
US:NYSE Investor Relations:
evogene.com/investor-relations
Company Research
Source: Yahoo! Finance
Total Revenue (Q3 2024): Approximately $1.8 million, down from $3.8 million in Q3 2023. Operating Loss (First Nine Months 2024): Approximately $17.6 million, down from $18.9 million in the same period of 2023. Operating Loss (Q3 2024): Approximately $7.5 million, up from $4.2 million in Q3 2023. Net Loss (First Nine Months 2024): Approximately $18 million, compared to $18.6 million in the same period of 2023. Net Loss (Q3 2024): Approximately $8.2 million, up from $3.9 million in Q3 2023. Cash and Cash Equivalents (As of September 30, 2024): Approximately $20 million. Projected Cash Usage (2024, Excluding Lavie Bio and Biomica): Approximately $8 million to $10 million, down from $12.5 million in 2023. General and Administrative Expenses (Q3 2024): Approximately $2.9 million, up from $1.5 million in Q3 2023. Research and Development Expenses (First Nine Months 2024): Approximately $13.2 million, down from $15.2 million in the same period of 2023. Financing Expenses N
Show less
Read more
Impact Snapshot
Event Time:
EVGN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
EVGN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
EVGN alerts
High impacting Evogene Ltd. - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
EVGN
News
- Evogene Ltd. (NASDAQ: EVGN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat
- Evogene Ltd. (NASDAQ: EVGN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat
- Evogene Ltd. (NASDAQ: EVGN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat
- Evogene Ltd. (NASDAQ: EVGN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat
- Evogene Reports Third Quarter 2024 Financial ResultsPR Newswire
EVGN
Earnings
- 3/7/24 - Beat
EVGN
Sec Filings
- 11/27/24 - Form 424B3
- 11/27/24 - Form 6-K
- 11/21/24 - Form 424B3
- EVGN's page on the SEC website